Current Limitations of Molecular Magnetic Resonance Imaging for Tumors as Evaluated With High-Relaxivity CD105-Specific Iron Oxide Nanoparticles

cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

(2011) Xiaoqiang Yang et al.   BIOMATERIALS

Molecular Magnetic Resonance Imaging Allows the Detection of Activated Platelets in a New Mouse Model of Coronary Artery Thrombosis

(2011) Daniel Duerschmied et al.   INVESTIGATIVE RADIOLOGY

Detectability of Her2 Positive Tumors Using Monoclonal Antibody Conjugated Iron Oxide Nanoparticles in MRI

(2011) M. A. Oghabian et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Theranostics With Multifunctional Magnetic Gold Nanoshells

(2010) Marites P. Melancon et al.   INVESTIGATIVE RADIOLOGY

Coating Optimization of Superparamagnetic Iron Oxide Nanoparticles for High T2Relaxivity

(2010) Sheng Tong et al.   NANO LETTERS

Inorganic nanoparticle-based contrast agents for molecular imaging

(2010) Eun Chul Cho et al.   TRENDS IN MOLECULAR MEDICINE

Radiolabeling of monoclonal anti-CD105 with 177Lu for potential use in radioimmunotherapy

(2009) So-Young Lee et al.   APPLIED RADIATION AND ISOTOPES

Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo

(2009) Chang-Moon Lee et al.   MAGNETIC RESONANCE IN MEDICINE

RGD-labeled USPIO Inhibits Adhesion and Endocytotic Activity of αvβ3-Integrin–expressing Glioma Cells and Only Accumulates in the Vascular Tumor Compartment

(2009) Fabian Kiessling et al.   RADIOLOGY

Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection

(2008) Geng Kou et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

(2008) C. von zur Muhlen et al.   CIRCULATION